Ontrak (NASDAQ:OTRK – Get Free Report) is set to announce its earnings results after the market closes on Wednesday, November 13th. Analysts expect the company to announce earnings of ($1.56) per share for the quarter. Ontrak has set its Q3 2024 guidance at EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.
Ontrak (NASDAQ:OTRK – Get Free Report) last issued its earnings results on Thursday, August 8th. The company reported ($2.85) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.50) by ($1.35). The business had revenue of $2.45 million during the quarter, compared to the consensus estimate of $2.60 million. Ontrak had a negative return on equity of 238.43% and a negative net margin of 222.54%. During the same quarter in the previous year, the firm posted ($27.60) earnings per share. On average, analysts expect Ontrak to post $-7 EPS for the current fiscal year and $-4 EPS for the next fiscal year.
Ontrak Stock Up 2.8 %
Shares of NASDAQ OTRK opened at $1.82 on Wednesday. The firm has a market cap of $7.68 million, a PE ratio of -0.05 and a beta of 2.59. The company’s fifty day simple moving average is $2.55 and its 200 day simple moving average is $3.28. The company has a quick ratio of 3.64, a current ratio of 3.64 and a debt-to-equity ratio of 0.43. Ontrak has a 12-month low of $1.75 and a 12-month high of $21.29.
Analysts Set New Price Targets
Read Our Latest Report on OTRK
About Ontrak
Ontrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.
Featured Stories
- Five stocks we like better than Ontrak
- Pros And Cons Of Monthly Dividend Stocks
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Industrial Products Stocks Investing
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
- Top Biotech Stocks: Exploring Innovation Opportunities
- Astera Labs’ Big Stock Jump: Can the Growth Be Sustained?
Receive News & Ratings for Ontrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ontrak and related companies with MarketBeat.com's FREE daily email newsletter.